SPIA
GILD icon

Steward Partners Investment Advisory’s Gilead Sciences GILD Stock Holding History

Steward Partners Investment Advisory’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.5M Buy
75,160
+3,796
+5% +$532K 0.05% 315
2025
Q4 		$8.76M Buy
71,364
+512
+0.7% +$62.2K 0.05% 327
2025
Q3 		$7.86M Buy
70,852
+22,079
+45% +$2.51M 0.05% 356
2025
Q2 		$5.41M Sell
48,773
-2,152
-4% -$229K 0.04% 407
2025
Q1 		$5.71M Buy
50,925
+5,107
+11% +$527K 0.05% 357
2024
Q4 		$4.23M Buy
45,818
+5,116
+13% +$461K 0.04% 419
2024
Q3 		$3.41M Buy
40,702
+5,286
+15% +$403K 0.03% 474
2024
Q2 		$2.43M Buy
35,416
+217
+0.6% +$14.5K 0.03% 524
2024
Q1 		$2.58M Buy
35,199
+3,044
+9% +$234K 0.03% 499
2023
Q4 		$2.6M Buy
32,155
+651
+2% +$50.7K 0.04% 436
2023
Q3 		$2.36M Buy
31,504
+3,055
+11% +$235K 0.04% 429
2023
Q2 		$2.19M Sell
28,449
-211
-0.7% -$16.8K 0.03% 456
2023
Q1 		$2.38M Buy
28,660
+328
+1% +$27.2K 0.04% 420
2022
Q4 		$2.43M Sell
28,332
-1,152
-4% -$91.2K 0.04% 400
2022
Q3 		$1.82M Buy
29,484
+940
+3% +$59.3K 0.03% 462
2022
Q2 		$1.76M Sell
28,544
-420
-1% -$26K 0.03% 467
2022
Q1 		$1.72M Sell
28,964
-15,687
-35% -$1M 0.03% 525
2021
Q4 		$3.24M Sell
44,651
-40,340
-47% -$2.78M 0.05% 357
2021
Q3 		$5.94M Buy
84,991
+7,622
+10% +$535K 0.1% 218
2021
Q2 		$5.33M Buy
77,369
+9,203
+14% +$615K 0.09% 234
2021
Q1 		$4.41M Sell
68,166
-4,961
-7% -$320K 0.08% 272
2020
Q4 		$4.26M Sell
73,127
-27,993
-28% -$1.69M 0.09% 222
2020
Q3 		$6.39M Buy
101,120
+3,165
+3% +$219K 0.16% 143
2020
Q2 		$7.54M Buy
97,955
+4,186
+4% +$321K 0.21% 121
2020
Q1 		$7.01M Buy
93,769
+14,227
+18% +$983K 0.26% 101
2019
Q4 		$5.17M Sell
79,542
-465
-0.6% -$30.3K 0.15% 149
2019
Q3 		$5.07M Buy
80,007
+41,487
+108% +$2.71M 0.17% 138
2019
Q2 		$2.6M Buy
38,520
+8,865
+30% +$583K 0.1% 212
2019
Q1 		$1.93M Buy
29,655
+511
+2% +$34K 0.08% 239
2018
Q4 		$1.82M Sell
29,144
-150
-0.5% -$10.5K 0.09% 236
2018
Q3 		$2.26M Sell
29,294
-645
-2% -$48.7K 0.11% 202
2018
Q2 		$2.12M Buy
29,939
+2,150
+8% +$152K 0.13% 183
2018
Q1 		$2.1M Buy
27,789
+2,183
+9% +$174K 0.14% 162
2017
Q4 		$1.83M Buy
25,606
+9,448
+58% +$717K 0.14% 162
2017
Q3 		$1.31M Buy
16,158
+2,145
+15% +$164K 0.13% 156
2017
Q2 		$991K Sell
14,013
-8,715
-38% -$580K 0.11% 177
2017
Q1 		$1.54M Buy
22,728
+19,138
+533% +$1.35M 0.23% 93
2016
Q4 		$257K Buy
+3,590
New +$267K 0.12% 152

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Steward Partners Investment Advisory's GILD Position: Q1 2026 in Review

Steward Partners Investment Advisory increased its Gilead Sciences (GILD) stake by 5.3% in Q1 2026, buying an estimated $532K and bringing the position to 75,160 shares worth $10.5M. The position accounts for 0.05% of the portfolio, ranked #315.

Steward Partners Investment Advisory first reported a position in GILD in Q4 2016 and has held it in 38 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Steward Partners Investment Advisory held 75,160 shares of Gilead Sciences worth $10.5M as of Q1 2026.
  • Steward Partners Investment Advisory bought 3,796 Gilead Sciences shares in Q1 2026, an estimated $532K.
  • Gilead Sciences made up 0.05% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #315 holding.
  • Steward Partners Investment Advisory first reported a position in Gilead Sciences in Q4 2016 and has held it in 38 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.